These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 23978649)
1. Internal heavy atom effect of Au(III) and Pt(IV) on hypocrellin A for enhanced in vitro photodynamic therapy of cancer. Zhou L; Ge X; Liu J; Zhou J; Wei S; Li F; Shen J Bioorg Med Chem Lett; 2013 Oct; 23(19):5317-24. PubMed ID: 23978649 [TBL] [Abstract][Full Text] [Related]
2. External heavy-atomic construction of photosensitizer nanoparticles for enhanced in vitro photodynamic therapy of cancer. Zhou L; Wei S; Ge X; Zhou J; Yu B; Shen J J Phys Chem B; 2012 Oct; 116(42):12744-9. PubMed ID: 22984941 [TBL] [Abstract][Full Text] [Related]
3. Complexation of Hypocrellin A with Al3+ in water solution and the photodynamic therapy study. Ma F; Huang H; Ge X; Yang X; Yang C; Han L; Zhou J; Zhou L Bioorg Med Chem Lett; 2013 Mar; 23(6):1689-92. PubMed ID: 23411082 [TBL] [Abstract][Full Text] [Related]
4. A new near infrared photosensitizing nanoplatform containing blue-emitting up-conversion nanoparticles and hypocrellin A for photodynamic therapy of cancer cells. Jin S; Zhou L; Gu Z; Tian G; Yan L; Ren W; Yin W; Liu X; Zhang X; Hu Z; Zhao Y Nanoscale; 2013 Dec; 5(23):11910-8. PubMed ID: 24129918 [TBL] [Abstract][Full Text] [Related]
5. 808 nm Light-triggered and hyaluronic acid-targeted dual-photosensitizers nanoplatform by fully utilizing Nd(3+)-sensitized upconversion emission with enhanced anti-tumor efficacy. Hou Z; Deng K; Li C; Deng X; Lian H; Cheng Z; Jin D; Lin J Biomaterials; 2016 Sep; 101():32-46. PubMed ID: 27267626 [TBL] [Abstract][Full Text] [Related]
6. Mitochondria-targeting photosensitizer-encapsulated amorphous nanocage as a bimodal reagent for drug delivery and biodiagnose in vitro. Zhou L; Liu JH; Ma F; Wei SH; Feng YY; Zhou JH; Yu BY; Shen J Biomed Microdevices; 2010 Aug; 12(4):655-63. PubMed ID: 20300855 [TBL] [Abstract][Full Text] [Related]
7. Interactions of CT-DNA with Hypocrellin A and its Al(3+)-Hypocrellin A complex. Ma F; Ge X; Huang H; Yang C; Han L; Zhou J; Yang X Spectrochim Acta A Mol Biomol Spectrosc; 2013 May; 109():158-63. PubMed ID: 23523758 [TBL] [Abstract][Full Text] [Related]
8. Effect of chelation to lanthanum ions on the photodynamic properties of hypocrellin A. Zhou J; Liu J; Xia S; Wang X; Zhang B J Phys Chem B; 2005 Oct; 109(41):19529-35. PubMed ID: 16853523 [TBL] [Abstract][Full Text] [Related]
9. A new Co(III)-hypocrellin B complex with enhanced photonuclease activity. Sun Y; Hou YJ; Zhou QX; Chen JR; Zhang BW; Wang XS J Inorg Biochem; 2011 Jul; 105(7):978-84. PubMed ID: 21561592 [TBL] [Abstract][Full Text] [Related]
10. Photosensitizer effects on cancerous cells: a combined study using synchrotron infrared and fluorescence microscopies. Chio-Srichan S; Réfrégiers M; Jamme F; Kascakova S; Rouam V; Dumas P Biochim Biophys Acta; 2008 May; 1780(5):854-60. PubMed ID: 18342635 [TBL] [Abstract][Full Text] [Related]
11. Effect of structural modifications on photosensitizing activities of hypocrellin dyes: EPR and spectrophotometric studies. Yuying H; Jingyi A; Lijin J Free Radic Biol Med; 1999 May; 26(9-10):1146-57. PubMed ID: 10381185 [TBL] [Abstract][Full Text] [Related]
12. Chelation of hypocrellin B with zinc ions with electron paramagnetic resonance (EPR) evidence of the photodynamic activity of the resulting chelate. Tian C; Xu S; Chen S; Shen J; Zhang M; Shen T Free Radic Res; 2001 Nov; 35(5):543-54. PubMed ID: 11767412 [TBL] [Abstract][Full Text] [Related]
13. Biophysical evaluation of two red-shifted hypocrellin B derivatives as novel PDT agents. Paul BT; Babu MS; Santhoshkumar TR; Karunagaran D; Selvam GS; Brown K; Woo T; Sharma S; Naicker S; Murugesan R J Photochem Photobiol B; 2009 Jan; 94(1):38-44. PubMed ID: 18977666 [TBL] [Abstract][Full Text] [Related]
14. Biodegradable hypocrellin derivative nanovesicle as a near-infrared light-driven theranostic for dually photoactive cancer imaging and therapy. Zheng X; Ge J; Wu J; Liu W; Guo L; Jia Q; Ding Y; Zhang H; Wang P Biomaterials; 2018 Dec; 185():133-141. PubMed ID: 30243149 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of vanadyl-hypocrellin A complex and its photodynamic properties research. Yang C; Ma F; Tang J; Han L; Wei S; Zhou L; Zhou J; Shen J; Wang F Bioorg Med Chem Lett; 2012 Aug; 22(15):5003-7. PubMed ID: 22749418 [TBL] [Abstract][Full Text] [Related]
16. Ultrasound-Enhanced Self-Exciting Photodynamic Therapy Based on Hypocrellin B. Ding Y; Liu W; Wu J; Zheng X; Ge J; Ren H; Zhang W; Lee CS; Wang P Chem Asian J; 2021 May; 16(10):1221-1224. PubMed ID: 33881805 [TBL] [Abstract][Full Text] [Related]
17. A new sol-gel silica nanovehicle preparation for photodynamic therapy in vitro. Zhou L; Liu JH; Zhang J; Wei SH; Feng YY; Zhou JH; Yu BY; Shen J Int J Pharm; 2010 Feb; 386(1-2):131-7. PubMed ID: 19922781 [TBL] [Abstract][Full Text] [Related]
18. New potential photodynamic therapeutic anti-cancer agents: synthesis and characterization of demethoxy amino-substituted hypocrellins. Wu T; Xu S; Shen J; Song A; Chen S; Zhang M; Shen T Anticancer Drug Des; 2000 Aug; 15(4):287-93. PubMed ID: 11200504 [TBL] [Abstract][Full Text] [Related]
19. Graphene oxide noncovalent photosensitizer and its anticancer activity in vitro. Zhou L; Wang W; Tang J; Zhou JH; Jiang HJ; Shen J Chemistry; 2011 Oct; 17(43):12084-91. PubMed ID: 21915922 [TBL] [Abstract][Full Text] [Related]
20. Photodynamic properties of hypocrellin A, complexes with rare Earth trivalent ions: role of the excited state energies of the metal ions. Zeng Z; Zhou J; Zhang Y; Qiao R; Xia S; Chen J; Wang X; Zhang B J Phys Chem B; 2007 Mar; 111(10):2688-96. PubMed ID: 17315917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]